Collaboration
At Bayer, collaboration is essential to our mission of advancing healthcare. We work closely with patients, healthcare professionals, and organisations to foster innovation and improve patient outcomes. Our commitment to transparency and ethical practices guides our collaborative efforts, ensuring that we create value for all stakeholders involved.
Transfers of Value to Healthcare Professionals and Healthcare Organisations
Supporting Healthcare Professionals and Healthcare Organisations (Transfers of Value)
Bayer is proud and committed to fostering transparency in its financial relations with healthcare professionals and organisations and believes that it creates trust in the pharmaceutical industry.
How Bayer Works Together with Healthcare Professionals
Industry and healthcare professionals collaborate in a range of activities in preclinical research, clinical development as well as clinical practice and patient outcome.
As the primary point of contact with patients, healthcare professionals offer invaluable and expert knowledge on patient outcomes and the management of diseases. This plays a crucial role in optimising our efforts to improve patient care, treatment options and patient outcomes.
What the EFPIA Disclosure Code is about
Bayer fully supports greater transparency in the relationship between the pharmaceutical industry and healthcare professionals and organisations and therefore ensures compliance with the EFPIA Disclosure Code.
Data Disclosure
In accordance with the EFPIA Disclosure Code Bayer discloses transfers of value connected to the development and commercialisation of prescription-only human pharmaceuticals to healthcare professionals and healthcare organisations.
The disclosed data include transfers of value in four main categories:
| Categories | Transfers of value | |
Healthcare Professionals | Healthcare Organisations | |
| Donations and grants | - | Whether monetary or other |
| Collaborative Working including Joint Working | - | Whether monetary or other |
| Events | 1. Registration fees 2. Travel & accommodation | 1. Sponsorship 2. Registration fees (if applicable) 3. Travel & accommodation |
| Services and consultancy | 1. Fees 2. Related expenses agreed in the contract (including, for example, travel, accommodation & registration fees) | |
| Research and development | Fees, travel & accommodation, and other related expenses that are covered in connection with the service | |
Get Access to the UK Data...
Learn More About our Disclosure Methodology
The general rules of the EFPIA Disclosure Code apply to all member companies and all companies will disclose transfers of value made to healthcare professionals and healthcare organizations in a pre-defined format. However, some details of the reporting methodology are left for the individual companies to decide in order to allow the necessary flexibility to adjust to the internal processes. This methodology note allows you to understand how Bayer in the UK is documenting and disclosing the relevant information.
PP-OTH-GB-1209 / September 2024